UN Global Compact  |  CEO Water Mandate

Great Britain Colombia Brazil

AstraZeneca

<% join_label %>

AstraZeneca

Show Full Map
Amazon
Area: 5888268 km2
Countries:
Brazil; Peru; Suriname; France; Colombia; Guyana; Bolivia; Venezuela; Ecuador
Cities:
Santa Cruz; Manaus; La Paz
PFAF ID:
HydroBasin Level:
Baseline Water Stress:
Water Quality Stress:
Sanitation Access Stress:
Click to view individual basin.
Location
Click Icon to Show on Map
City & Country
,
()

Quick Info

Countries: China, Egypt, India, Mexico, Puerto Rico, Sweden, United Kingdom of Great Britain and Northern Ireland, United States of America
Regions: India, Panuco, Penner River, Potomac River, Rio Lerma, Santiago, Trinity River (Texas)
Organization SDGs:
Includes Sustainable Development Goals from the organization and its locations.
Increase Access to Water, Sanitation, Hygiene (SDG 6.1 & 6.2)
Water Quality (SDG 6.3)
Water Use Efficiency (SDG 6.4)
Organization Tags:
Includes tags from the organization and its locations.
Nature-Based Solutions
Sustainable Withdrawals
Chemicals Management
Industrial Wastewater
Services Offered: Monitoring & evaluation
Stakeholder engagement & facilitation
Org. Type: Business
Org. Size: Very Large (1000+ Employees)
Industry Sector: Biotech, health care & pharma
Language: English
Org. Website: www.astrazeneca.com
Org. Source: User
Profile Completion: 89%
Coalition: No

Organization Overview

We want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. Our ambition is to stop the progress of these often degenerative, debilitating, and life-threatening conditions, achieve remission, and one day cure them.

Clean and plentiful water is vital for the development and manufacture of these life-changing medicines. We use freshwater for cleaning and cooling, and we also requ…

Read More

We want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. Our ambition is to stop the progress of these often degenerative, debilitating, and life-threatening conditions, achieve remission, and one day cure them.

Clean and plentiful water is vital for the development and manufacture of these life-changing medicines. We use freshwater for cleaning and cooling, and we also require relatively small volumes of purified water for chemical syntheses and producing biological medicines. Although water use in our industry is low relative to other sectors, significant volumes of water are required to produce the raw materials we use to make our products and, at a local level, our sites have the potential to deplete water sources and impact water quality. We recognise that it is key to focus on not only how much water we use, but also the longterm impacts of where we use it.

We are committed to water stewardship and have targets, initiatives and goals across our operations to reduce our impacts and be a positive actor in the river basins where we operate:

• At AstraZeneca sites: Decoupling water demand from business growth with our 2015-2025 global water efficiency goal key performance indicators; aspiring to develop context-based science-based water targets.

• In drug development: Adopting Resource Efficiency targets to reduce the water demand of the drugs we develop; conducting life Cycle Assessments to calculate the water footprint across the whole product life cycle including the raw materials used to make the drug substance.

• Maintaining water quality: Preventing pollution by applying safe discharge limits for active pharmaceutical ingredients produced or formulated our manufacturing operation.

• In our supply chain: Applying these safe discharge limits across our supply chain to prevent pollution from supplying that manufacture active pharmaceutical ingredients for us; Implementing a Supplier Sustainability Framework.

• In the communities where we operate: Supporting basin-level collective action; leading the development of science-based water targets. Starting in 2024, we will invest $5 million per year to fund nature restoration and water stewardship projects in the communities where we operate.

Latest updates

No current notifications are found for the projects, organizations, and other topics you are currently following.

Following

Partner Organizations


None found.

Partner Projects


At the start of 2015, the company initiated a €10 million (US$ 11.3 million) partnership with the European Commission under the Innovative Medicines Initiative. This project – called Intelligent Assessment of Pharmaceuticals in the Environment – aims to develop screening … Learn More

The Pharmaceutical Supply Chain Initiative (PSCI) is a group of pharmaceutical and healthcare companies who share a vision of better, social, environmental and economic outcomes in the communities where we buy. We believe that collectively PSCI members can share knowledge … Learn More

Suggested Resources

View the full list of 300+ resources at the Water Stewardship Toolbox

WBCSD Learn More

CEO Water Mandate; Water Witness International; WaterAid; WBCSD Learn More

IPIECA Learn More

UNICEF; WHO Learn More

River Threat Netwrok Learn More

Swedish Textile Water Initiative Learn More

Alliance for Water Stewardship Learn More

WaterAid Learn More

CEO Water Mandate Learn More

McKinsey Learn More

UN Water Learn More

AT&T; EDF; Global Environmental Management Institute (GEMI) Learn More

Sarah Argoud
Primary Contact  
John Atkinson
Admin  

   Loading Matches

No lessons found.